Therapeutic Drug Monitoring During Maintenance Infliximab Therapy for Immune-Mediated Diseases

This randomized clinical trial assesses the effect of therapeutic drug monitoring vs standard therapy on sustained disease control without disease worsening among patients with immune-mediated inflammatory diseases (rheumatoid arthritis, spondyloarthritis, psoriatic arthritis, ulcerative colitis, Crohn disease, or psoriasis) undergoing maintenance therapy with infliximab.
Source: JAMA - Category: General Medicine Source Type: research